Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Heptinstall S and Bevan J How can we inhibit 5-HT-induced platelet aggregation and why should we bother? 1988 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2465956
Bodzenta-Lukaszyk A et al. Blood platelet function in patients with obliterative arteriosclerosis of the lower limbs. 1988 Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. pmid:2465957
Terashita Z et al. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock. 1988 J. Cardiovasc. Pharmacol. pmid:2468048
Smith SK and Kelly RW Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium. 1988 J. Reprod. Fertil. pmid:3422322
Alessandrì MG et al. PAF-induced histamine release in the isolated perfused rat kidney. 1988 Int J Tissue React pmid:2456276
Martin TR et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. 1988 J. Appl. Physiol. pmid:2457008
Yoshida K et al. PAF inhibitors of microbial origin. Studies on diketopiperazine derivatives. 1988 Prog Biochem Pharmacol pmid:2457219
Croft KD et al. Effect of dietary fish oils on the formation of leukotriene B4 and B5, thromboxane and platelet activating factor by rat leukocytes. 1988 Clin. Exp. Pharmacol. Physiol. pmid:2856061
Anderson G and Fennessy M Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig. 1988 Br. J. Pharmacol. pmid:3145088
Sessler CN et al. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep. 1988 J. Appl. Physiol. pmid:3145934
Del Monte M and Subissi A Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites. 1988 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3149718
Hofmann B et al. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat. 1988 Biomed. Biochim. Acta pmid:3150268
Bahr T et al. Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models. 1988 Biomed. Biochim. Acta pmid:3150272
Hofmann B et al. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets. 1988 Thromb. Res. pmid:3381200
Rao GH Measurement of ionized calcium in normal human blood platelets. 1988 Anal. Biochem. pmid:3382012
Banks JB et al. Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol. 1988 Biochim. Biophys. Acta pmid:3382692
Shalit M et al. Platelet activating factor increases expression of complement receptors on human neutrophils. 1988 J. Leukoc. Biol. pmid:2842423
Miyazawa K et al. Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species. 1988 J. Immunol. pmid:3385211
Archer CB et al. Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man. 1988 J. Invest. Dermatol. pmid:3385217
Taylor RR et al. Time dependence of whole blood aggregation in response to platelet activating factor (PAF). 1988 Thromb. Haemost. pmid:3388292
Powling MJ and Hardisty RM Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. 1988 Thromb. Haemost. pmid:3388294
Pirotzky E et al. Cyclosporine-induced nephrotoxicity: preventive effect of a PAF-acether antagonist, BN 52063. 1988 Transplant. Proc. pmid:3388505
Ward SG and Westwick J Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. 1988 Br. J. Pharmacol. pmid:3390650
Rosenthal MD et al. Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells. 1988 Lipids pmid:3148797
Mullane KM et al. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. 1988 Ann. N. Y. Acad. Sci. pmid:2837948
Sato N et al. Microvascular basis of gastric mucosal protection. 1988 J. Clin. Gastroenterol. pmid:3183337
Goodwin JS and Behrens T Role of lipoxygenase metabolites of arachidonic acid in T cell activation. 1988 Ann. N. Y. Acad. Sci. pmid:2837956
Abraham WM The role of leukotrienes in allergen-induced late responses in allergic sheep. 1988 Ann. N. Y. Acad. Sci. pmid:2837960
Mazière JC et al. PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts. 1988 FEBS Lett. pmid:3402608
Hellegouarch A et al. Effects of BN 52063 and other agents inhibiting platelet-activating factor-induced contractile responses in rat portal vein. 1988 J. Pharm. Pharmacol. pmid:2907020
Subissi A et al. Effects of anti-asthma drugs on PAF-induced death in mice. 1988 Prostaglandins pmid:2907663
Lima MC et al. Mediators of inflammation and antagonism of experimental pleurisy in the rat by fenspiride. 1988 Rhinol. Suppl. pmid:2907679
Smith LJ et al. Mechanism of platelet activating factor-induced bronchoconstriction in humans. 1988 Am. Rev. Respir. Dis. pmid:3195800
O'Neill C et al. Embryo-derived platelet-activating factor. Its diagnostic and therapeutic future. 1988 Ann. N. Y. Acad. Sci. pmid:3195924
Ninio E et al. Biosynthesis of paf-acether. XI. Regulation of acetyltransferase by enzyme-substrate imbalance. 1988 Biochim. Biophys. Acta pmid:3196734
Hsueh W and Gonzalez-Crussi F Ischemic bowel necrosis induced by platelet-activating factor: an experimental model. 1988 Methods Achiev Exp Pathol pmid:3045496
Kumar R et al. Production and effects of platelet-activating factor in the rat brain. 1988 Biochim. Biophys. Acta pmid:3196741
Braquet P et al. Effects of the specific platelet-activating factor antagonists, BN 52021 and BN 52063, on various experimental gastrointestinal ulcerations. 1988 Eur. J. Pharmacol. pmid:3046952
Bette-Bobillo P and Bienvenue A Platelet-activating-factor-induced serum-albumin release from rabbit platelets in the absence of calcium. 1988 Eur. J. Biochem. pmid:3197724
Barr R et al. The effect of platelet activating factor on electron transport of spinach chloroplasts. 1988 Biochem. Biophys. Res. Commun. pmid:3048258
Cueva JP and Hsueh W Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis. 1988 Gut pmid:3197995
Camussi G et al. Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. 1988 J. Exp. Med. pmid:3049910
Bass DA et al. Selective priming of rate and duration of the respiratory burst of neutrophils by 1,2-diacyl and 1-O-alkyl-2-acyl diglycerides. Possible relation to effects on protein kinase C. 1988 J. Biol. Chem. pmid:3198643
Cahill M et al. Effect of des arginine9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. 1988 Agents Actions pmid:3051930
Lewis MS et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. 1988 J. Clin. Invest. pmid:3198764
Page CP et al. Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. 1988 Agents Actions Suppl. pmid:3051932
Makino S [Platelet activating factor in allergic reaction]. 1988 Arerugi pmid:3052368
Janero DR et al. Specific binding of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the intact canine platelet. 1988 Thromb. Res. pmid:3413730
Misawa M and Takata T Effects of platelet-activating factor on rat airways. 1988 Jpn. J. Pharmacol. pmid:3199608
Altman R et al. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation. 1988 Clin. Pharmacol. Ther. pmid:3416553
Chu KM et al. Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog. 1988 J. Pharmacol. Exp. Ther. pmid:3418522
Pai JK et al. Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes. 1988 Biochem. Biophys. Res. Commun. pmid:3422154
Weisman SM et al. Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction. 1988 Biochem. Pharmacol. pmid:2840083
Kochanek PM et al. Cerebrovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. 1988 J. Cereb. Blood Flow Metab. pmid:3392115
Michel L et al. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. 1988 J. Immunol. pmid:3397536
Morrison WJ and Shukla SD Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin. 1988 Mol. Pharmacol. pmid:2827000
Steel LK et al. Quantitative, functional and biochemical alterations in the peritoneal cells of mice exposed to whole-body gamma-irradiation. I. Changes in cellular protein, adherence properties and enzymatic activities associated with platelet-activating factor formation and inactivation, and arachidonate metabolism. 1988 Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. pmid:3286551
Barnes PJ et al. Platelet-activating factor as a mediator of allergic disease. 1988 J. Allergy Clin. Immunol. pmid:3286723
Nakayama R and Saito K [PAF and its physiological significance in normal tissue]. 1988 Seikagaku pmid:3286791
Dulioust A et al. Immunoregulatory functions of paf-acether (platelet-activating factor). 1988 Prog. Clin. Biol. Res. pmid:3071809
Chung KF et al. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man. 1988 J. Allergy Clin. Immunol. pmid:3288683
Lee TC et al. Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens. 1988 J. Biol. Chem. pmid:2828351
Romero A et al. [Effect of corticosteroids, quinacrine and L-652, 731 on experimental aggregation of polymorphonuclear leukocytes induced by complement and platelet activating factor (PAF)]. 1988 Rev. Esp. Fisiol. pmid:3072620
Page CP and Robertson DN The role of PAF in altered airway responsiveness. 1988 Prog. Clin. Biol. Res. pmid:3289016
Nieto ML et al. Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. Involvement of the cholinephosphotransferase pathway in response to the phorbol esters. 1988 J. Biol. Chem. pmid:2828363
Arnout J et al. Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man. 1988 Br J Clin Pharmacol pmid:3289599
Ponpipom MM et al. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. 1988 Biochem. Biophys. Res. Commun. pmid:2829894
Braquet P et al. Platelet activating factor as a mediator in cerebral ischemia and related disorders. 1988 Biomed. Biochim. Acta pmid:3073761
O'Donnell SR and Barnett CJ pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. 1988 Br. J. Pharmacol. pmid:3293683
Giovannini L et al. N-acetyl-beta-glucosaminidase (NAG) and alpha-glycosidase released by PAF in isolated perfused rat kidney. 1988 Int J Tissue React pmid:3294206
Esplugues JV and Whittle BJ Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat. 1988 Br. J. Pharmacol. pmid:3349230
Kobayashi T et al. Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate (MOTP) in rats and dogs. 1988 Xenobiotica pmid:3354232
Arnoux B et al. Accumulation of platelets and eosinophils in baboon lung after paf-acether challenge. Inhibition by ketotifen. 1988 Am. Rev. Respir. Dis. pmid:3354991
Nakayama R et al. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity. 1988 Biochem. Biophys. Res. Commun. pmid:3355555
Kramer RM et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. 1988 Biochim. Biophys. Acta pmid:3355850
McGowan HM et al. Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. 1988 Clin. Sci. pmid:3356112
Abraham WM and Wanner A Inflammatory mediators of asthma. 1988 Pediatr. Pulmonol. pmid:2455882
Kosano H and Takatani O Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. 1988 Cancer Res. pmid:3262419
Berstad A et al. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. 1988 Scand. J. Gastroenterol. pmid:3262915
Morley J et al. Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. 1988 Agents Actions Suppl. pmid:3262989
Subissi A and Criscuoli M Effects of LG 30435 on different platelet activating factor-induced responses. 1988 Agents Actions Suppl. pmid:3262990
Heuer H and Casals-Stenzel J Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. 1988 Agents Actions Suppl. pmid:3262991
Ontell SJ et al. Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. 1988 Gastroenterology pmid:3263295
Breviario F et al. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. 1988 J. Immunol. pmid:3263425
Page CP The role of platelet-activating factor in asthma. 1988 J. Allergy Clin. Immunol. pmid:3276759
Altman R et al. Why single daily dose of aspirin may not prevent platelet aggregation. 1988 Thromb. Res. pmid:3140408
Piper PJ et al. Release of leukotrienes from porcine and human blood vessels by immunological and nonimmunological stimuli. 1988 Ann. N. Y. Acad. Sci. pmid:2837950
Ryan US et al. Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. 1988 J. Appl. Physiol. pmid:3209566
Nogami M et al. [Effects of a platelet activating factor (PAF) antagonist CV-3988 on acute gastric erosions in rats by water immersion and restrained stress, and by ethanol]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3210345
Schwertschlag US et al. Nonimmunological alterations of glomerular filtration by s-PAF in the rat kidney. 1988 Kidney Int. pmid:3210538
Rubin RM and Rosenbaum JT A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. 1988 Biochem. Biophys. Res. Commun. pmid:3260779
Fisher RA et al. AGEPC: a potent calcium-dependent chemical mediator in the liver. 1988 Adv. Exp. Med. Biol. pmid:3213685
Mickelson JK et al. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. 1988 J. Mol. Cell. Cardiol. pmid:3216407
Rubin RM et al. Prostaglandin-independent inhibition of ocular vascular permeability by a platelet-activating factor antagonist. 1988 Arch. Ophthalmol. pmid:3261165
Bussolino F [Production of PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in the chick retina during embryogenesis]. 1988 Ann. Ist. Super. Sanita pmid:3218801
Dillon PK et al. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships. 1988 Inflammation pmid:3220518
van Delft JL et al. Specific receptor sites for PAF in iris and ciliary body of the rabbit eye. 1988 Curr. Eye Res. pmid:2854038
Lohmann HF et al. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086. 1988 Lancet pmid:2903365
Shirinsky VP et al. Agonist-induced polyphosphoinositide breakdown in cultured human endothelial and vascular smooth muscle cells. 1988 Health Psychol pmid:2854052
Colton CA and Gilbert DL An endogenous source of the superoxide anion in the central nervous system. 1988 Basic Life Sci. pmid:2854971